AU2001260695A1 - Malto-oligosaccharide derivatives and use thereof - Google Patents
Malto-oligosaccharide derivatives and use thereofInfo
- Publication number
- AU2001260695A1 AU2001260695A1 AU2001260695A AU6069501A AU2001260695A1 AU 2001260695 A1 AU2001260695 A1 AU 2001260695A1 AU 2001260695 A AU2001260695 A AU 2001260695A AU 6069501 A AU6069501 A AU 6069501A AU 2001260695 A1 AU2001260695 A1 AU 2001260695A1
- Authority
- AU
- Australia
- Prior art keywords
- hyperglycemia
- alpha
- prophylactic
- diabetes
- integer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical class O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 title 1
- 201000001421 hyperglycemia Diseases 0.000 abstract 3
- 101710171801 Alpha-amylase inhibitor Proteins 0.000 abstract 2
- 239000003392 amylase inhibitor Substances 0.000 abstract 2
- 206010012601 diabetes mellitus Diseases 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 230000000069 prophylactic effect Effects 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 229940124597 therapeutic agent Drugs 0.000 abstract 2
- 102000004139 alpha-Amylases Human genes 0.000 abstract 1
- 108090000637 alpha-Amylases Proteins 0.000 abstract 1
- 229940024171 alpha-amylase Drugs 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000001165 hydrophobic group Chemical group 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/02—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Seasonings (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
The present invention provides a substance which strongly inhibits human alpha -amylase and is effective for the prevention and treatment of hyperglycemia, for example, diabetes and the diseases caused thereby, and an alpha -amylase inhibitor and a prophylactic or therapeutic agent for hyperglycemia containing the said substance as active principle. Maltoligosaccharide derivatives represented by the following formula: <CHEM> (wherein n is an integer of 0 to 2; m is an integer of 0 to 2; and X represents a hydrogen atom or a hydrophobic group) or their hydrates or physiologically acceptable salts are provided, and they are contained as active principle to prepare an alpha -amylase inhibitor and a prophylactic or therapeutic agent for hyperglycemia such as diabetes. <IMAGE>
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000-168363 | 2000-06-06 | ||
| JP2000168363 | 2000-06-06 | ||
| PCT/JP2001/004653 WO2001094367A1 (en) | 2000-06-06 | 2001-06-01 | Malto-oligosaccharide derivatives and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001260695A1 true AU2001260695A1 (en) | 2001-12-17 |
Family
ID=18671377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001260695A Abandoned AU2001260695A1 (en) | 2000-06-06 | 2001-06-01 | Malto-oligosaccharide derivatives and use thereof |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6939858B2 (en) |
| EP (1) | EP1291349B1 (en) |
| JP (1) | JP4373671B2 (en) |
| AT (1) | ATE278701T1 (en) |
| AU (1) | AU2001260695A1 (en) |
| DE (1) | DE60106246T2 (en) |
| WO (1) | WO2001094367A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2514931A1 (en) | 2003-01-30 | 2004-08-12 | Sankyo Company Limited | Oligosaccharide derivative |
| TW200608967A (en) | 2004-07-29 | 2006-03-16 | Sankyo Co | Pharmaceutical compositions containing with diabetic agent |
| TW200612968A (en) * | 2004-07-29 | 2006-05-01 | Sankyo Co | Oligosaccharide derivatives containing with heterocycle |
| JP2006063074A (en) * | 2004-07-29 | 2006-03-09 | Sankyo Co Ltd | Medicinal composition containing diabetes therapeutic agent |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2064527B (en) * | 1979-12-08 | 1984-05-02 | Nippon Shinyaku Co Ltd | Moranoline derivatives and process for preparation thereof |
| JP3909735B2 (en) * | 1999-02-22 | 2007-04-25 | キッコーマン株式会社 | Maltooligosaccharide derivatives and uses thereof |
-
2001
- 2001-06-01 JP JP2002501915A patent/JP4373671B2/en not_active Expired - Fee Related
- 2001-06-01 WO PCT/JP2001/004653 patent/WO2001094367A1/en not_active Ceased
- 2001-06-01 AT AT01934498T patent/ATE278701T1/en not_active IP Right Cessation
- 2001-06-01 EP EP01934498A patent/EP1291349B1/en not_active Expired - Lifetime
- 2001-06-01 AU AU2001260695A patent/AU2001260695A1/en not_active Abandoned
- 2001-06-01 DE DE60106246T patent/DE60106246T2/en not_active Expired - Lifetime
- 2001-06-01 US US10/297,408 patent/US6939858B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20040006046A1 (en) | 2004-01-08 |
| WO2001094367A1 (en) | 2001-12-13 |
| US6939858B2 (en) | 2005-09-06 |
| EP1291349A1 (en) | 2003-03-12 |
| ATE278701T1 (en) | 2004-10-15 |
| DE60106246D1 (en) | 2004-11-11 |
| EP1291349A4 (en) | 2003-08-27 |
| EP1291349B1 (en) | 2004-10-06 |
| JP4373671B2 (en) | 2009-11-25 |
| DE60106246T2 (en) | 2005-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL148384A0 (en) | Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof | |
| AP2000001860A0 (en) | Hypolipidemic benzothiazepine compounds. | |
| AU2003225617A1 (en) | Thiadiazolylpiperazine derivatives useful for treating or preventing pain | |
| NO20074657L (en) | Nitrogen-containing aromatic ring compounds | |
| MY141661A (en) | 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
| EP1400529A4 (en) | Glucopyranosyloxypyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate therefor | |
| AU2267395A (en) | Benzofuran derivatives useful as inhibitors of bone resorption | |
| IL108520A0 (en) | Imidazopyridine derivatives, processes for the preparation thereof, and pharmaceutical compositions containing them | |
| CA2336412A1 (en) | Medicament for treatment of diabetes | |
| ES2098947T3 (en) | DERIVATIVES OF BETA, BETA-DIMETIL-4-PIPERIDINOETANAMINE AS INHIBITORS OF CHOLESTEROL BIOSYNTHESIS. | |
| PT630252E (en) | PREPARATION OF RAMNOLIPID-BASED PHARMACEUTICAL AGAINST DERMATOLOGICAL DISEASES | |
| EP1156057A4 (en) | Malto-oligosaccharide derivatives and uses thereof | |
| SE0201837D0 (en) | Chemical compounds | |
| AU2001260695A1 (en) | Malto-oligosaccharide derivatives and use thereof | |
| EP1179342A4 (en) | Immediate release medicinal compositions for oral use | |
| MY122570A (en) | Benzamide derivatives and drugs containing the same | |
| NO950177D0 (en) | Pharmacologically active derivatives | |
| EA200600022A1 (en) | APPLICATION OF DERIVATIVE BICYCLO [2.2.1] HEPTANA TO PREPARE NEUROPROTECTIVE PHARMACEUTICAL COMPOSITIONS | |
| DE60104589D1 (en) | Therapeutic agent for the treatment of dermatitis | |
| SE0103272D0 (en) | Chemical compounds | |
| HUP9801985A2 (en) | Use of cystine derivatives for the preparation of pharmaceutical compositions useful for the treatment of restenosis |